In addition to Mel-Juso, we selected 2 additional cell lines with activating mutations in NRAS (SK-Mel-30 and SK-Mel-2) as well as 2 established melanoma cell lines with a BRAFV600E mutation (A375 and SK-Mel-28) for comparison. This evidence concerns the gene NRAS and melanoma.